STALICLA’s CEO, Lynn-Allison Durham and Head of Discovery, Laura Perez Cano, will present at the 11th Clinical Biomarkers & World CDx EU Summit this Wednesday, March 24th.

STALICLA’s CEO, Lynn-Allison Durham and Head of Discovery, Laura Perez Cano, will sit on the expert Panel “Changing Healthcare Landscape Influences on Precision Medicine Delivery in the EU” at the 11th Clinical Biomarkers & World CDx EU Summit this Wednesday, March 24th at 10:00 CET.

Do not miss the opportunity to learn more about how STALICLA is expanding the field of applications of precision medicine to deliver better treatments for NDDs and improve the quality of life of millions living with neuropsychiatric and behavioral disorders.

Link to the event:

Word CDX Europe
 

Link to the event:

Guide